呈和科技（688625）：“呈”势向上，再攀高峰

Investment Rating - The report initiates coverage with a "Buy" rating for the company [10][12]. Core Insights - The company is a leader in the domestic nucleating agent and synthetic hydrotalcite market, with strong competitiveness in antioxidant and NDO composite additives. The penetration rate of domestic nucleating agents and synthetic hydrotalcite remains low, indicating potential for continued growth in the company's main business. Projected net profits for 2025, 2026, and 2027 are estimated at 360 million, 439 million, and 518 million yuan respectively [3][10]. Company Overview - The company has been deeply engaged in the polymer material additive sector for over 20 years, establishing itself as a leader in nucleating agents and synthetic hydrotalcite. It has successfully developed and marketed nucleating agent products, gaining recognition from major downstream manufacturers and expanding into both domestic and international markets [6][22]. Nucleating Agents - The demand for nucleating agents is growing significantly, with domestic demand increasing from 4,600 tons in 2016 to 9,520 tons in 2022, reflecting a compound annual growth rate of 12.9%. In 2023, China's nucleating agent demand accounted for approximately 27% of the global market, second only to North America [7][61]. - The company benefits from a competitive edge as domestic nucleating agent prices are generally 1/3 to 1/2 lower than imported products, driven by lower production costs and reduced logistics expenses [7]. Synthetic Hydrotalcite - Synthetic hydrotalcite is primarily used as a heat stabilizer in PVC production and as a halogen absorber in polyolefin resin production. The demand for synthetic hydrotalcite has maintained rapid growth, with domestic leading companies achieving technological breakthroughs and accelerating import substitution [8][24]. Antioxidants - In 2023, the company entered the antioxidant sector through acquisitions, enhancing its product line. The antioxidant products are primarily specialized hindered phenolic antioxidants, widely used in various applications including nylon and polyurethane [9][10]. Financial Analysis - The company has shown steady revenue growth, with significant contributions from its core products, particularly nucleating agents. From 2018 to 2024, the sales volume of nucleating agents increased from 2,349 tons to 9,728 tons, a growth rate exceeding 314% [38][43]. - The company maintains a high gross margin, consistently above 40%, and has optimized its expense structure, enhancing its market competitiveness and profitability [45][52]. Investment Recommendations - Given the company's strong market position, growth potential in nucleating agents and synthetic hydrotalcite, and the recent expansion into antioxidants, the report recommends a "Buy" rating for investors looking for opportunities in the polymer additive sector [10][12].